Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Pierre Fabre reports antioxidants with neurologic activity

March 15, 1996

Cyclahexadiene derivatives reported by Bayer for AD

March 15, 1996

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

Yissum claims novel anticonvulsants

March 15, 1996

Hematopoietic research at Temple University

March 15, 1996

Sanofi claims CCK-A agonists for obesity

March 15, 1996

Glaxo Wellcome reports antitumor drugs

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

Lilly reports drugs for osteoarthritis

March 15, 1996

Hoechst claims RTase inhibitors

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...